Bryn Mawr Trust CO Procept Bio Robotics Corp Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 764 shares of PRCT stock, worth $49,774. This represents 0.0% of its overall portfolio holdings.
Number of Shares
764
Previous 794
3.78%
Holding current value
$49,774
Previous $63,000
3.17%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$335 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$227 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$114 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$97.1 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$78.6 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.91B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...